HC Wainwright & Co. Reiterates Curis (CRIS) Buy Recommendation
Fintel reports that on September 29, 2023, HC Wainwright & Co. reiterated coverage of Curis (NASDAQ:CRIS) with a Buy recommendation. Analyst Price Forecast Suggests 7.13% Downside
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|